recombinant human Complement Receptor Type 1 (CDX-1135) / Celldex  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
recombinant human Complement Receptor Type 1 (CDX-1135) / Celldex
NCT01791686: Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease

Terminated
1
1
US
CDX-1135, TP10, sCR1
Celldex Therapeutics
Dense Deposit Disease, Membranoproliferative Glomerulonephritis Type II, C3 Glomerulonephritis
03/14
03/14

Download Options